INTRODUCTION
Retinopathy of prematurity (ROP) is a major cause of blindness in premature infants. 1, 2 This disorder of abnormal vascularization of the retina tends to occur in low-birth-weight neonates exposed to higher supplemental oxygen. In the United States, 400 infants per year are blinded and 4300 infants per year develop severe visual impairment due to ROP. 3, 4 Previous studies have shown that African±American infants are less likely to develop severe ROP and require surgical intervention. 5 We have previously reported from a different institution that Candida sepsis is an independent risk factor for the development of severe ROP and the need for laser therapy; 6 others were unable to confirm these findings. 7 Postnatal steroids are known to increase the risk for fungal sepsis. 8 The effect of postnatal steroids on ROP is controversial. 9 ± 12 This study was undertaken to investigate the association of postnatal steroids and fungal sepsis in the development of severe
OBJECTIVE:
The objective of this study was to evaluate the role of postnatal dexamethasone use and fungal sepsis in the development of severe retinopathy and progression to laser therapy.
BACKGROUND:
Postnatal steroids have been frequently used in the management of infants with chronic lung disease, airway edema, and hypotension, but their use is not free from adverse effects. Postnatal dexamethasone use has been associated with increased risk for the development of fungal sepsis, but the influence of glucocorticoid therapy on retinopathy of prematurity ( ROP ) is controversial. Candida sepsis has been shown to be associated with severe ROP and the need for laser therapy in some studies but not in others.
STUDY DESIGN:
Medical records of all < 1000 g birth weight infants ( n = 158 ) admitted to Louisiana State University Health Sciences Center between July 1, 1996 and June 30, 1999 were reviewed. After exclusion of those infants who either died ( n = 25 ) or transferred ( n = 3 ) before eye examination, demographic and clinical data of 130 infants were analyzed by -squared analysis, MannWhitney U test, t -test, analysis of variance, and logistic regression. All data are mean SD.
RESULTS:
Gestational age was 26.4 1.7 weeks; birth weight was 797 130 g. Twenty -six infants were Caucasian, the rest African ± American. Seventyfive ( 58% ) received antenatal steroids. Eighty -eight ( 68% ) of the infants received postnatal steroids. All infants were exclusively fed premature infant formulae. Sepsis developed in 44 ( 34% ) infants and fungal sepsis in 14 ( 11% ) . Incidence of ROP was 77% ( 100 / 130 ) , severe ROP ( stage !3 ) 52% ( 68 ) . Severe ROP was more frequent in Caucasian infants ( p = 0.005 ) and in infants who received postnatal dexamethasone ( p 0.0001 ) . The development of threshold ROP ( zone 1 or 2 with stage 3 + , five contiguous or eight total clock hours of the retina ) and requirement for laser therapy were higher in Caucasians ( p = 0.0002 ) and in infants with fungal sepsis ( p = 0.001 ) . Antenatal steroids had no effect on the severity of ROP or the need for laser treatment. Postnatal dexamethasone use was significantly associated with fungal sepsis 13 / 14 ( 93% ) . After controlling for gestational age, race, days on supplemental oxygen, and fungal sepsis, cumulative postnatal dexamethasone use was independently associated with severe ROP [ OR 1.2 ( 1.04 ± 1.33 ) ] , and fungal sepsis [ OR 8.2 ( 2.0 ± 33.0 ) ] was independently associated with the need for laser therapy.
CONCLUSIONS:
Postnatal steroid use is an independent risk factor for development of severe ROP. The risk of threshold ROP requiring laser treatment was higher in infants who developed fungal sepsis. Figure 1 . Demographic data (birth weight < 1000 g) . ROP and the need for laser therapy in extremely low-birth-weight ( <1000 g) infants.
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MATERIALS AND METHODS
Medical records of all <1000 g birth weight infants (n=158) admitted to Louisiana State University Health Sciences Center Neonatal Intensive Care Unit between July 1, 1996 and June 30, 1999 were reviewed. After exclusion of deaths and transfers before eye examination, demographic and clinical data of 130 infants were collected. ROP was diagnosed by the Pediatric Ophthalmologist according to criteria of the International Classification of Retinopathy of Prematurity. 13 The most severe stage of ROP during the hospital stay was recorded for each infant. The first ophthalmologic examination was conducted at 4 to 6 weeks of age. Subsequent examinations were done at the discretion of ophthalmologist, based on the findings of the first examination. Prethreshold ROP Dexamethasone cumulative dose (mg/kg birth weight) was calculated for the entire hospital stay. All infants were followed until ROP regressed or required the laser therapy.
Data were analyzed by -squared analysis, Mann-Whitney U test, t-test, analysis of variance, and logistic regression. Data are expressed as meanSD and odds ratio (OR) with 95% confidence interval (CI). A p value of <0.05 was considered statistically significant.
RESULTS
One hundred fifty-eight infants with birth weights <1000 g were admitted to the Neonatal Intensive Care Nursery during the study period (Figure 1 ). Of these, 25 infants died and three transferred out before ophthalmologic examinations. Among infants that transferred out, two were African±American and one was Caucasian. Clinical data were reviewed for the remaining 130 infants. Twenty-six infants were Caucasians and the rest African±Americans. Out of 130 infants, 119 were inborn. All infants were exclusively fed premature infant formulae.
The birth weight ( SD) of the entire group (excluding the infants that expired and the ones that were transferred out before the ophthalmology examination) was 797 g ( 130 g) and the gestational age at birth was 26.4 weeks ( 1.7 weeks). The overall incidence of ROP was 77%. Fourteen patients (11%) had fungal sepsis. Fourteen blood cultures were positive; eight for Candida albicans, one for C. parapsilosis, two for Malassezia furfur, and three for M. patchydermatis. Data are presented in Tables 1 and 2 . Caucasian infants had a higher incidence of severe ROP and requirement for laser therapy (Table 3) . Infants with fungal sepsis showed increased requirement for laser therapy (Table 4) . Fungal sepsis was significantly associated with the use of postnatal dexamethasone (Table 5) . Also, infants who developed fungal sepsis were exposed to a larger cumulative dexamethasone dose compared to infants without fungal sepsis (Table 4) .
Our study demonstrated that the more the cumulative dose of postnatal dexamethasone exposure, the more severe the ROP (Figure 2 and Table 6 ). Also, the more the cumulative dose of postnatal dexamethasone, the more the incidence of fungal sepsis (Table 4) .
After controlling for gestational age, race, fungal sepsis, and days on supplemental oxygen, postnatal cumulative dexamethasone use was independently associated with severe ROP (Table 7) . After controlling for gestational age, race, days on supplemental oxygen, and postnatal cumulative dexamethasone use, fungal sepsis was independently associated with the requirement for laser treatment (Table 8) . By altering birth weight for gestational age in multiple logistic regression for both severity of ROP and for requirement for laser treatment, outcome of our results were not much different.
DISCUSSION
This study was conducted to evaluate the association of postnatal dexamethasone use and fungal sepsis in the development of severe ROP and requirement for surgical intervention. We focused on infants with birth weights <1000 g because they are at the highest risk for developing advanced ROP. The overall incidence of ROP in our study was 77%, which is comparable to the incidence described in other large studies.
14 As would be expected from the current understanding of ROP, the incidence correlated significantly with gestational age and days on supplemental oxygen.
Uemera et al. 15 reported that a steroid-induced vasoproliferative retinopathy occurred in young rabbits following dexamethasone treatment. Conflicting retrospective studies have been published to show association between postnatal steroids and ROP. Our results showed significant association between postnatal dexamethasone use and severe ROP in a dose-dependent manner.
This study also confirmed our previous study that demonstrated an association between fungal sepsis and a requirement for laser therapy. Caucasian race had much higher incidence of severe ROP as well as requirement for laser therapy. To control for these potentially confounding variables, multiple logistic regression was performed to evaluate for any independent association of postnatal steroids, race, and fungal sepsis with ROP as well as for the need for a therapeutic intervention. Postnatal dexamethasone use and Caucasian race were independently associated with increased severity of ROP, while race and fungal sepsis were independent risk factors for requirement of surgical therapy for advanced ROP. As mentioned earlier, fungal sepsis was seen in 93% of patients who received postnatal dexamethasone. This means that infants on postnatal dexamethasone use are at higher risk for fungal infections and this may potentially increase the risk for requirement of laser therapy.
A more recent study of Karlowicz et al. 7 did not show Candida sepsis to be an independent risk factor for ROP. Differing results are most likely multifactorial. This study controlled for race; however, this was not an urban population, excluded infants admitted at >3 days of age, and did not include duration of oxygen exposure in the regression analyses.
C. albicans is known to interact with vascular endothelial cells in a number of different ways. The exact mechanism of induction of angiogenesis by C. albicans is unknown. It is possible that there may be an angiogenic substance that is produced by Candida species that may be responsible for the increased severity of ROP that we have observed in our patients. It is not known if candidemia modulates the expression of known angiogenic factors, such as vascular endothelial growth factor, that have been implicated in the pathogenesis of ROP. 16, 17 Our study demonstrated that 5 of 14 fungal infections were not Candida. The mechanism of action of those causing increase in severity of ROP is unknown. 
CONCLUSION
We confirmed our previous study that fungal sepsis is a risk factor for severe ROP and requirement for laser treatment. We also confirmed that postnatal dexamethasone use increases the risk for fungal sepsis. Our study showed that postnatal dexamethasone use is a risk factor for the development of severe ROP. ROP is a multifactorial disease. Infants at risk for ROP need to be monitored closely. The data suggest that infants with postnatal dexamethasone use, fungal sepsis, and Caucasian race need to be monitored closely for the development of advanced stages of ROP so that they may receive early surgical intervention. Postnatal dexamethasone should be used only for specific absolute indications with possible minimal doses and in short courses. All undesirable consequences of corticosteroid therapy in preterm infants may not yet be fully known; therefore, cautious use of these potent pharmacologic agents seems well advised. Very low birth weight, the presence and duration of central venous catheters, preceding use of corticosteroids, frequent use of broad-spectrum antibiotics, and parenteral administration of hypertonic dextrose solutions or lipid emulsions have been implicated as predisposing factors for fungal infections in premature infants. 8 Judicious use of clinical practices may decrease the risks of fungal infections as they do indeed seem to demonstrate a significant relation to severe ROP. We recommend ophthalmologic examinations at least weekly, if not more frequently, in all infants <1000 g with fungal sepsis and/or treatment with intravenous corticosteroids. Consideration should also be given to earlier treatment than at traditional threshold criteria in these groups of infants.
